a Nationwide PEM.

* there are related drugs with significant problems;

* the target disease is of low risk and any increased risk arising from therapy would adversely affect the benefit-risk balance;

* safe treatment options are already available and any increase in risk would be unacceptable;

* another drug of the same class is being monitored or considered, which provides the added value of a comparator and also raises the question of equity for the sponsors.

Drug Free Life

Drug Free Life

How To Beat Drugs And Be On Your Way To Full Recovery. In this book, you will learn all about: Background Info On Drugs, Psychological Treatments Statistics, Rehab, Hypnosis and Much MORE.

Get My Free Ebook

Post a comment